Home › NDC Lookup › RxCUI directory › RxCUI 861601

Pentamidine isethionate 300 MG Injection — RxCUI 861601

RxNorm drug concept · Semantic clinical drug
RxCUI 861601 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861601
Official namePentamidine isethionate 300 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)931 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pentamidine Oral Inhalation: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It helps prevent Pneumocystis pneumonia, a serious lung infection, in people with HIV who are at high risk. That means a past episode of PJP or a low CD4+ count (200/mm³ or lower).
  • The inhaled form is breathed in as a mist through a nebulizer. In the studies, this was done every two or four weeks. Your prescriber will tell you your schedule, so follow it clos...
  • Cough, tiredness, decreased appetite, dizziness, fever, wheezing and shortness of breath were commonly reported. Some people notice a bad taste, nausea or diarrhea. Tell your care...
  • Get help for trouble breathing, swelling, fainting, a racing or irregular heartbeat, severe stomach pain, or signs of low blood sugar like shakiness or confusion. These can be seri...
📖 Read our full Pentamidine Oral Inhalation guide →

🕸️ Concept Web — How Pentamidine isethionate 300 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pentamidine isethionate 300 MG Injection RxCUI 861601

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pentamidine 7994
    • Pentamidine isethionate 7995
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pentam 495527
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pentamidine Injection 1811403
    • Pentamidine isethionate Injection 2648108
    • Pentamidine Injectable Product 1164781
    • Pentamidine isethionate Injectable Product 2661822
    • Pentamidine Injection [Pentam] 1811406
    • Pentamidine isethionate Injection [Pentam] 2655281
    • Pentam Injectable Product 1184584
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pentamidine isethionate 300 MG SCDC · 1811402
  • Pentamidine Injection SCDF · 1811403
  • Pentamidine isethionate Injection SCDFP · 2648108
  • Pentamidine Injectable Product SCDG · 1164781
  • Pentamidine isethionate Injectable Product SCDGP · 2661822

Brand-Name Concepts

  • Pentamidine isethionate 300 MG Injection [Pentam] SBD · 861604
  • Pentamidine isethionate 300 MG [Pentam] SBDC · 1811405
  • Pentamidine Injection [Pentam] SBDF · 1811406
  • Pentamidine isethionate Injection [Pentam] SBDFP · 2655281
  • Pentam Injectable Product SBDG · 1184584
  • Pentam BN · 495527

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 861601 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-1101-02 10 VIAL, SINGLE-USE in 1 CARTON (0121-1101-02) / 300 mg in... Pentamidine Isethionate PAI Holdings, LLC dba PAI Pharma 2026-06-12
13925-0515-10 10 VIAL in 1 TRAY (13925-515-10) / 300 mg in 1 VIAL Pentamidine Isethionate Seton Pharmaceuticals 2018-04-01
23155-0748-41 10 VIAL, SINGLE-DOSE in 1 CARTON (23155-748-41) / 300 mg in... pentamidine isethionate Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2021-01-08
39822-3050-02 10 VIAL in 1 CARTON (39822-3050-2) / 3 mL in 1 VIAL PENTAMIDINE ISETHIONATE XGen Pharmaceuticals DJB, Inc. 2023-04-04
63323-0113-10 10 VIAL in 1 TRAY (63323-113-10) / 3 mL in 1 VIAL (63323-11... Pentam 300 Fresenius Kabi USA, LLC 2001-01-16
Observed labelers: Fresenius Kabi USA, LLC (1) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (1) · PAI Holdings, LLC dba PAI Pharma (1) · Seton Pharmaceuticals (1) · XGen Pharmaceuticals DJB, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2516 Pentamidine non-comp unit 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.